# Hypotheses: ECM Mechanics x Enhancer Regulation

**Session:** 2026-03-26-targeted-001 (Cycle 1)
**Generator model:** Opus 4.6
**Fields:** Mechanobiology (ECM stiffness) x Epigenomics (genomic enhancer regulation)
**Generated:** 2026-03-26
**Count:** 5 hypotheses

---

## Hypothesis 1: Stiffness-Dependent Super-Enhancer Nucleation via YAP-Recruited BRD4-MED1 Phase Condensates

**Novelty claim:** No study has examined whether ECM stiffness selectively activates super-enhancers (as opposed to typical enhancers) at YAP target loci. The specific claim is that stiff ECM (~10 kPa) causes a qualitative phase transition from typical enhancer to super-enhancer status at a subset of YAP/TEAD-bound loci, driven by BRD4-MED1 condensate nucleation that is concentration-dependent on YAP-recruited EP300 activity. This differs from Tsaryk 2022 (which used shear stress, not stiffness, and did not examine super-enhancer rank-ordering) and from Yu 2025 (which studied KDM6B/H3K27me3 at promoters, not super-enhancer assembly). PubMed confirms zero papers for "ECM stiffness" AND "H3K27ac" and zero for "matrix stiffness" AND "super-enhancer."

**Mechanism:**

Step 1 -- ECM stiffness (>5 kPa threshold) promotes integrin beta-1 (ITGB1) clustering at focal adhesions, activating PTK2/FAK [GROUNDED: canonical integrin signaling; STRING ITGB1-PTK2: 0.997]. FAK activates Src-family kinases and RhoA/ROCK, which inhibit LATS1/2 kinase [GROUNDED: Dupont et al., Nature 2011; LATS1-YAP1 STRING: 0.999]. With LATS1/2 inhibited, unphosphorylated YAP1 translocates to the nucleus (timescale: 15-60 min) and binds TEAD1 transcription factors [GROUNDED: YAP1-TEAD1 STRING: 0.999].

Step 2 -- Nuclear YAP1/TEAD1 complexes recruit the histone acetyltransferase EP300 to TEAD-bound enhancers [PARAMETRIC: YAP1-EP300 STRING: 0.692, medium confidence; TEAD1-EP300: 0.537, medium-low]. EP300 catalyzes H3K27 acetylation (kcat ~5/min; rate-limiting step is recruitment, not catalysis) at these enhancers [GROUNDED: EP300 is the canonical H3K27ac writer; Whitworth 2024 confirmed EP300 requirement for shear-responsive genes]. This initial H3K27ac deposition creates binding sites for BRD4 bromodomain reader [GROUNDED: BRD4 bromodomain recognizes H3K27ac; EP300-BRD4 STRING: 0.988].

Step 3 -- Here is the novel mechanistic claim: at typical enhancers, EP300-deposited H3K27ac recruits modest levels of BRD4. But at TEAD-dense genomic clusters (where multiple YAP/TEAD binding sites are within 10-50 kb, as occurs at super-enhancer-forming regions), the local concentration of BRD4 and MED1 exceeds the critical concentration for phase separation (~100-300 nM based on in vitro measurements of BRD4 IDR domains; Sabari et al., Science 2018). The result is a stiffness-dependent phase transition: soft ECM (<3 kPa) produces sparse H3K27ac at individual TEAD enhancers (typical enhancer state), while stiff ECM (>8 kPa) produces sufficient BRD4/MED1 accumulation at TEAD-dense loci to nucleate phase-separated transcriptional condensates, converting these regions to super-enhancer status.

Step 4 -- The super-enhancer transition is predicted to be non-linear: a sharp increase in H3K27ac signal intensity at specific loci (identifiable by rank-ordering H3K27ac ChIP-seq signal, the standard ROSE algorithm criterion) occurs between 5-10 kPa but not proportionally below or above this range, reflecting the thermodynamics of phase separation (nucleation barrier). This predicts that the stiffness-to-enhancer relationship at these specific loci is switch-like, not graded.

**Predicted observation:** H3K27ac ChIP-seq on MCF10A mammary epithelial cells cultured on polyacrylamide (PAA) hydrogels at 1, 5, 10, and 25 kPa will reveal: (a) at 1 kPa, TEAD-motif-containing enhancers near YAP target genes (CTGF, CYR61, ANKRD1) are classified as typical enhancers by ROSE algorithm; (b) at 10 kPa, the same loci cross the super-enhancer threshold (top ~3% of H3K27ac ranked signal); (c) the transition is sharper than a linear stiffness-H3K27ac relationship would predict (Hill coefficient >2 when fitting stiffness vs. H3K27ac at these specific loci). BRD4 ChIP-seq will show condensate-like broad-domain enrichment at the super-enhancer loci on stiff but not soft substrates.

**Falsification:** (1) If H3K27ac at TEAD-bound enhancers increases linearly with stiffness rather than showing a switch-like transition, the condensate nucleation model is wrong and the response is a simple graded dose-response. (2) If 1,6-hexanediol (condensate dissolver, 5% for 2 min) abolishes super-enhancer H3K27ac signal on stiff substrates but does not reduce typical enhancer signal, this supports the condensate dependence. If hexanediol has no differential effect, condensates are not required. (3) If BRD4 inhibition (JQ1, 500 nM) prevents the typical-to-super-enhancer transition on stiff substrates without affecting YAP nuclear localization, BRD4 is required downstream of YAP for super-enhancer assembly.

**Test protocol:** MCF10A cells on PAA hydrogels (1, 3, 5, 8, 10, 25 kPa; n=2 biological replicates per stiffness). Culture 48 hr for steady-state. Perform H3K27ac ChIP-seq + BRD4 ChIP-seq + ATAC-seq + RNA-seq at each stiffness. Analyze: (i) ROSE algorithm super-enhancer calling at each stiffness; (ii) TEAD1 motif enrichment in stiffness-responsive enhancers; (iii) Hill coefficient fitting for H3K27ac signal vs. stiffness at TEAD-proximal loci. Pharmacological: JQ1 (BRD4 inhibitor, 500 nM) and 1,6-hexanediol (5%, 2 min) at 10 kPa to test condensate requirement. Optionally: OptoDroplet-BRD4 system to test whether light-induced BRD4 condensation at TEAD loci is sufficient for super-enhancer formation on soft (1 kPa) substrates.

**Confidence:** 0.55 -- The individual components are well-established (YAP mechanosensing, EP300 enhancer writing, BRD4/MED1 condensates at super-enhancers). The specific claim that stiffness triggers a condensate-dependent typical-to-super-enhancer switch at TEAD loci is speculative but mechanistically plausible. The phase separation field is active but stiffness as a trigger for condensate nucleation at enhancers has not been proposed.

**Groundedness:** 6 -- YAP/TEAD mechanosensing is well-grounded (Dupont 2011). EP300 writing H3K27ac is canonical biochemistry. BRD4/MED1 condensates at super-enhancers are established (Sabari et al., Science 2018). The bridge claims (YAP1-EP300: 0.692, TEAD1-EP300: 0.537) are medium-confidence STRING interactions. The novel claim (condensate nucleation threshold crossed by stiffness-dependent EP300 activity at TEAD clusters) is parametric.

**Key uncertainty:** Whether the local BRD4/MED1 concentration at TEAD-proximal enhancers can reach the phase separation threshold (~100-300 nM) via the YAP-EP300-H3K27ac-BRD4 cascade alone, or whether additional co-factors are required. In vivo phase separation concentrations may differ substantially from in vitro measurements.

**Counter-evidence:** (1) Phase separation at super-enhancers is controversial -- several groups argue that BRD4 clusters are not true liquid-liquid phase-separated condensates but rather cooperative binding assemblies (McSwiggen et al., Genes Dev 2019). If the "condensates" are not phase-separated, the nucleation threshold model (and the predicted switch-like behavior) does not hold. (2) YAP target genes like CTGF may already be at super-enhancer status in epithelial cells regardless of stiffness, if constitutive TEAD binding is sufficient. (3) The TEAD1-EP300 STRING score is only 0.537, suggesting this interaction may not be robust enough to drive sufficient EP300 recruitment for condensate nucleation.

**Cross-domain creativity score:** 2 (mechanobiology + epigenomics + biophysics of phase separation)

---

## Hypothesis 2: Coordinated Bivalent-to-Active Enhancer Conversion at Developmental Loci via Dual ECM-Stiffness-Controlled Enzymes (KDM6B + EP300)

**Novelty claim:** ECM stiffness simultaneously upregulates KDM6B (which removes H3K27me3 from the repressive Polycomb mark) and activates EP300 (which writes H3K27ac at the same H3K27 lysine residue). Since H3K27me3 and H3K27ac are mutually exclusive on the same residue, this implies that ECM stiffness could coordinately convert bivalent enhancers (carrying both H3K4me1 and H3K27me3, poised but inactive) to active enhancers (carrying H3K4me1 and H3K27ac). No paper has studied this coordinated bivalent-to-active enhancer switch under ECM stiffness gradients. Yu 2025 studied KDM6B and H3K27me3 at EMT gene promoters (not enhancers). Whitworth 2024 studied EP300 under shear stress (not stiffness). The specific coordination of both enzymes acting on the same lysine at enhancer elements under stiffness gradients is novel.

**Mechanism:**

Step 1 -- Bivalent enhancers are defined by co-occurrence of H3K4me1 (enhancer mark) and H3K27me3 (Polycomb repressive mark) [GROUNDED: Rada-Iglesias et al., Nature 2011 characterized bivalent/poised enhancers in human ESCs]. These enhancers are poised for activation during lineage commitment but remain inactive because H3K27me3 blocks the acetylation of the same lysine. For a bivalent enhancer to become active, two events must occur at the same nucleosome: H3K27me3 must be removed AND H3K27ac must be deposited.

Step 2 -- ECM stiffness controls both required enzymes. Route 1 (KDM6B arm): increased ECM stiffness (10-30 kPa) upregulates KDM6B mRNA and protein expression, increasing H3K27me3 demethylase activity at gene regulatory regions [GROUNDED: Yu et al., MCB 2025; confirmed by ChIP-qPCR at Snail/Twist promoters in thyroid cancer cells on PAA substrates]. Route 2 (EP300 arm): stiff ECM activates YAP nuclear translocation [GROUNDED: Dupont et al., 2011], and YAP/TEAD recruits EP300 to target enhancers [PARAMETRIC: YAP1-EP300 STRING 0.692, supported by Whitworth 2024 showing EP300 requirement for mechanically responsive genes under shear stress, but not directly shown for stiffness-driven YAP targets]. The two routes converge on the same H3K27 residue: KDM6B removes the methyl group, EP300 adds the acetyl group.

Step 3 -- The coordination claim is the novel element: the hypothesis predicts that at bivalent enhancers near developmental genes (e.g., enhancers controlling RUNX2 for osteogenesis, SOX9 for chondrogenesis, PPARG for adipogenesis), ECM stiffness acts as a binary switch. On soft ECM (<3 kPa), KDM6B expression is low and YAP is cytoplasmic, so H3K27me3 persists at bivalent enhancers and EP300 is not recruited -- enhancers remain poised. On stiff ECM (>10 kPa), KDM6B removes H3K27me3 AND EP300 deposits H3K27ac -- completing the bivalent-to-active conversion. Crucially, this predicts that pharmacological inhibition of EITHER enzyme alone should be sufficient to block the switch: GSK-J4 (KDM6B inhibitor) should preserve H3K27me3, preventing acetylation even if EP300 is present, while A-485 (EP300 catalytic inhibitor) should allow H3K27me3 removal but prevent H3K27ac deposition, leaving enhancers in a "stripped" (neither mark) state.

Step 4 -- Cell type specificity prediction: the bivalent-to-active conversion should occur at different enhancer subsets depending on the cell type's developmental potential. In mesenchymal stem cells (MSCs) on stiff ECM (~25-40 kPa), bivalent enhancers near osteogenic genes (RUNX2, SP7/Osterix) should convert to active enhancers. On intermediate stiffness (~8-12 kPa, muscle-range), bivalent enhancers near myogenic genes (MYOD1) should preferentially activate. This tissue-specific selectivity emerges because KDM6B and EP300 act globally, but only enhancers that also have cell-type-specific TF binding (e.g., TEAD + lineage TFs) will be fully activated.

**Predicted observation:** Sequential ChIP (re-ChIP) for H3K27me3 then H3K27ac at candidate developmental enhancers (identified by H3K4me1 ChIP-seq) in human MSCs cultured on 1 kPa, 10 kPa, and 40 kPa PAA hydrogels for 72 hr. At 1 kPa: enhancers near RUNX2, PPARG carry both H3K27me3 and H3K4me1 (bivalent). At 40 kPa: RUNX2 enhancers lose H3K27me3, gain H3K27ac (active). At 10 kPa: PPARG enhancers may begin transitioning while RUNX2 enhancers are partially activated (intermediate state). Genome-wide: CUT&Tag for H3K27me3 + H3K27ac + H3K4me1 will reveal a stiffness-dependent decrease in bivalent enhancers (H3K4me1+/H3K27me3+) with a matched increase in active enhancers (H3K4me1+/H3K27ac+) specifically at developmental loci.

**Falsification:** (1) If H3K27me3 loss at bivalent enhancers occurs without concomitant H3K27ac gain (i.e., enhancers go from bivalent to "stripped" rather than bivalent to active), then the two enzymes are not coordinately regulated by stiffness. (2) If GSK-J4 (KDM6B inhibitor) on stiff substrates does NOT preserve H3K27me3 at bivalent enhancers, then KDM6B is not the relevant demethylase under stiffness (could be UTX/KDM6A instead). (3) If A-485 (EP300 inhibitor) on stiff substrates does NOT prevent H3K27ac deposition, CBP rather than EP300 may be the relevant acetyltransferase. (4) If bivalent enhancers genome-wide respond uniformly to stiffness (no cell-type selectivity), the lineage TF gating model is wrong.

**Test protocol:** Human bone marrow-derived MSCs (commercially available, e.g., Lonza PT-2501) on PAA hydrogels at 1, 10, 25, 40 kPa (n=3 biological replicates per stiffness). 72 hr culture in growth medium (no differentiation supplements). CUT&Tag for H3K4me1, H3K27me3, H3K27ac genome-wide. Sequential ChIP (re-ChIP) at candidate loci (RUNX2, PPARG, SOX9 enhancers). Pharmacological: GSK-J4 (5 uM, KDM6B inhibitor) and A-485 (3 uM, EP300 inhibitor) at 40 kPa to dissect individual enzyme contributions. Western blot for KDM6B, EP300, YAP nuclear/cytoplasmic fractionation at each stiffness.

**Confidence:** 0.60 -- KDM6B stiffness-responsiveness is directly shown (Yu 2025). EP300 mechanosensitive recruitment is supported by shear stress data (Whitworth 2024) and YAP-EP300 interaction (STRING 0.692). The bivalent enhancer concept is well-established in developmental biology. The specific coordination at enhancers under stiffness is the novel claim.

**Groundedness:** 7 -- KDM6B upregulation by stiffness: directly grounded (Yu 2025). H3K27me3/H3K27ac mutual exclusivity on H3K27: canonical biochemistry [GROUNDED]. Bivalent enhancers in development: established (Rada-Iglesias 2011). EP300 recruitment by YAP: medium-confidence STRING + shear stress data. The coordination of both enzymes at enhancer resolution under stiffness: parametric/novel.

**Key uncertainty:** Yu 2025 demonstrated KDM6B at promoters in thyroid cancer cells, not at enhancers in MSCs. Whether KDM6B acts at distal enhancers (not just promoters) under ECM stiffness is unverified. KDM6B may be recruited to promoter-proximal regions only.

**Counter-evidence:** (1) KDM6B may not be the primary H3K27me3 demethylase at enhancers -- UTX (KDM6A) has been reported to be more enhancer-associated (Lee et al., Cell 2007). (2) The temporal dynamics may not align: KDM6B demethylation is slow (hours) while EP300 recruitment via YAP could be faster (30-120 min), so the two processes might not be coordinated in time. (3) In some cell types, stiff ECM might not upregulate KDM6B (this was shown only in thyroid cancer cells; MSCs could differ).

**Cross-domain creativity score:** 2 (mechanobiology + developmental epigenomics)

---

## Hypothesis 3: ECM Stiffness Reorganizes Enhancer-Promoter Loop Topology at YAP Target Gene Clusters via CTCF/Cohesin Redistribution

**Novelty claim:** No study has performed Hi-C or Micro-C under ECM stiffness gradients. The hypothesis proposes that ECM stiffness does not merely change histone marks at individual enhancers but reorganizes the 3D genome architecture by altering CTCF/cohesin loop extrusion patterns at YAP-responsive gene clusters. This is mechanistically distinct from all existing mechanoepigenetic studies, which focus on 1D epigenetic marks (H3K27ac, H3K27me3, H3K9me3) without considering 3D topology. PubMed co-occurrence: "ECM stiffness" AND "Hi-C" = 0 papers; "matrix stiffness" AND "enhancer-promoter loop" = 0 papers.

**Mechanism:**

Step 1 -- The LINC complex transmits mechanical forces directly from the cytoskeleton to the nuclear lamina and chromatin [GROUNDED: LMNA-SUN2 STRING: 0.999; forces of ~30 pN at chromatin, 15x above the ~2 pN nucleosome unwrapping threshold]. These forces are not uniformly distributed across the nucleus -- they are concentrated at nuclear envelope attachment points (emerin, SUN1/2 domains) and along actin-lamin connections, creating anisotropic force fields within the nucleus [GROUNDED: LINC complex mechanics reviewed in Miroshnikova 2022].

Step 2 -- Cohesin-mediated loop extrusion is an ATP-dependent process where cohesin rings slide along chromatin fiber until they encounter CTCF boundary elements in convergent orientation [GROUNDED: canonical loop extrusion model, Fudenberg et al., Cell Reports 2016]. The hypothesis proposes that mechanical tension on chromatin from the LINC complex alters the kinetics of cohesin loop extrusion: chromatin under tension is more extended and accessible, reducing cohesin's sliding friction and increasing extrusion rate. Conversely, regions not under direct mechanical tension (e.g., those in nuclear interior loci not tethered to the lamina) retain baseline extrusion kinetics [PARAMETRIC: no direct measurement of cohesin extrusion rate under mechanical tension exists].

Step 3 -- At YAP target gene clusters (e.g., the CTGF/CYR61 loci on chromosome 1, the ANKRD1 locus on chromosome 10), CTCF boundaries define topologically associating domains (TADs) that contain both enhancers and promoters. On soft ECM (<3 kPa), these TAD boundaries are maintained at default positions, and enhancer-promoter contacts within the TAD follow baseline probability. On stiff ECM (>8 kPa), increased nuclear tension from the LINC complex alters cohesin dynamics within these TADs, specifically at loci tethered near nuclear envelope attachment points. This shifts the equilibrium of enhancer-promoter loop contacts: stiffness-responsive enhancers are brought into more frequent contact with their target promoters, while insulated contacts across TAD boundaries remain blocked by CTCF.

Step 4 -- The critical prediction distinguishing this from simple histone mark changes: some gene regulatory changes under ECM stiffness should be dependent on 3D loop reorganization (detectable by Hi-C/Micro-C) rather than merely on H3K27ac gain. Specifically, if CTCF boundary elements near YAP target genes are mutated (via CRISPR deletion of specific CTCF sites), the stiffness-dependent gene activation should be partially de-coupled from H3K27ac status -- i.e., enhancers could gain H3K27ac on stiff substrates but fail to activate target promoters without proper loop architecture.

**Predicted observation:** Micro-C on MCF10A cells at 1 kPa vs. 10 kPa PAA hydrogels (48 hr culture) will reveal: (a) no global changes in A/B compartment ratios (compartments are largely determined by cell type, not acute signals); (b) specific strengthening of enhancer-promoter loop contacts at YAP target gene TADs (CTGF, CYR61, ANKRD1) on stiff substrates; (c) differential insulation scores at TAD boundaries adjacent to YAP target genes (weakened insulation or shifted boundary positions on stiff ECM); (d) loop contact frequency changes that correlate with, but are not fully explained by, H3K27ac changes (indicating a structural component beyond epigenetic marks).

**Falsification:** (1) If Micro-C shows no significant changes in loop architecture between 1 kPa and 10 kPa, the 3D topology component is negligible and all stiffness-dependent regulation occurs at the 1D epigenetic level. (2) If WAPL overexpression (which accelerates cohesin turnover and collapses loops) on stiff substrates does not reduce YAP target gene expression despite maintained H3K27ac, then loop contacts are not required for stiffness-dependent gene activation. (3) If A/B compartments shift genome-wide (not just at specific TADs), the effect is too broad to be YAP-specific and likely reflects general chromatin decompaction.

**Test protocol:** MCF10A on PAA hydrogels at 1 kPa and 10 kPa (n=2 biological replicates per condition; Micro-C requires ~200M read pairs per replicate). 48 hr culture. Perform Micro-C + H3K27ac CUT&Tag + RNA-seq. Analysis: (i) Loop calling (Mustache or HiCCUPS) at YAP target gene neighborhoods; (ii) insulation score at TAD boundaries flanking CTGF, CYR61, ANKRD1; (iii) virtual 4C from YAP target gene promoters to quantify enhancer-promoter contact frequency. Genetic perturbation: CRISPR deletion of CTCF sites flanking CTGF enhancer (identified by CTCF ChIP-seq) to test whether loop disruption uncouples H3K27ac gain from gene activation.

**Confidence:** 0.45 -- The 3D topology hypothesis is plausible but more speculative than the histone mark hypotheses. Cohesin dynamics under mechanical tension have not been measured. The effect may be too subtle to detect given current Hi-C resolution limits and the modest timescale (48 hr).

**Groundedness:** 4 -- LINC complex force transmission: grounded (STRING, Miroshnikova 2022). Cohesin loop extrusion model: grounded (Fudenberg 2016). YAP target gene loci and TAD structure: grounded (publicly available Hi-C data). The specific claim that mechanical tension alters cohesin extrusion kinetics: entirely parametric with no direct experimental support. The claim that CTCF boundaries shift under stiffness: speculative.

**Key uncertainty:** Whether LINC-transmitted forces create sufficient local tension at specific genomic loci to measurably alter cohesin dynamics. The 30 pN force at the nuclear envelope may dissipate before reaching specific TADs in the nuclear interior, making the effect genome-position-dependent and potentially undetectable at most loci.

**Counter-evidence:** (1) A/B compartments and TAD boundaries are remarkably stable across cell states and perturbations (Rao et al., Cell 2017 showed TADs are robust to many perturbations). Mechanical force may simply be insufficient to reorganize these structures. (2) If stiffness-dependent gene regulation is fully explained by YAP-EP300-H3K27ac at enhancers (Hypothesis 1), there may be no additional information in 3D topology changes. (3) Sun 2020 showed that nuclear interior genes respond to force while periphery genes resist -- this is the opposite of what a LINC-complex-mediated topology model would predict (periphery should be more affected by LINC forces).

**Cross-domain creativity score:** 3 (mechanobiology + epigenomics + chromosome biology/biophysics)

---

## Hypothesis 4: Lamina-Associated Domain Enhancers as a Mechanical Selectivity Filter -- Stiffness-Resistant Repression Creates Binary Gene Response Categories

**Novelty claim:** Sun 2020 showed that nuclear interior genes respond to mechanical force (H3K9me3 demethylation) while nuclear periphery genes resist. No study has applied this finding specifically to ENHANCERS, asking: do enhancers in lamina-associated domains (LADs) constitute a stiffness-resistant "brake" that constrains which genes can be mechanically activated? The hypothesis proposes that the genome's response to ECM stiffness is partitioned into two fundamentally different categories based on enhancer location: non-LAD enhancers (nuclear interior) gain H3K27ac on stiff ECM, while LAD-embedded enhancers (nuclear periphery, H3K9me3-marked) remain silenced regardless of stiffness. This creates a mechanical selectivity filter encoded in 3D genome architecture.

**Mechanism:**

Step 1 -- LADs are megabase-scale chromatin domains anchored to the nuclear lamina (lamin A/C, lamin B1) via direct lamin-chromatin interactions and lamina-associated protein complexes (LAP2beta, emerin) [GROUNDED: LADs defined by DamID, Guelen et al., Nature 2008; ~35-40% of the genome is in LADs in most cell types]. LAD chromatin is enriched for H3K9me2/3 and H3K27me3 and depleted for H3K27ac [GROUNDED: Kind et al., Cell 2015 showed LADs are transcriptionally repressive]. Enhancers within LADs are silenced by this repressive environment.

Step 2 -- ECM stiffness upregulates lamin A/C expression and stabilizes the nuclear lamina [GROUNDED: Xu et al., Materials Today Bio 2023; Swift et al., Science 2013 showed lamin A scales with tissue stiffness]. This creates a paradox: stiff ECM increases lamin A/C, which should STRENGTHEN LAD anchoring and H3K9me3 enrichment at the periphery, making LAD-embedded enhancers MORE resistant to activation. Simultaneously, stiff ECM activates YAP/EP300 and upregulates KDM6B, which should activate enhancers in the nuclear interior (non-LAD, euchromatic regions). The net result is a divergent response: stiff ECM activates non-LAD enhancers (via YAP/EP300) while REINFORCING silencing of LAD-embedded enhancers (via increased lamin A/C → stronger H3K9me3 anchoring).

Step 3 -- The selectivity filter has functional consequences: genes whose critical enhancers are in LADs cannot be activated by stiffness alone, even if they contain TEAD/YAP binding motifs. Genes whose enhancers are in non-LAD compartments are stiffness-responsive. This predicts that the set of stiffness-responsive genes is determined not just by transcription factor binding (YAP/TEAD) but by the 3D nuclear position of their enhancers. For example: if the key enhancer for gene X is in a LAD, gene X will be stiffness-insensitive even if it has a perfect TEAD motif in its enhancer.

Step 4 -- The model makes a strong prediction about tissue-specific differences: in cell types where a developmental gene's enhancer has been relocated OUT of a LAD (a known event during differentiation; Peric-Hupkes et al., Mol Cell 2010), that gene becomes stiffness-responsive. In cell types where the enhancer remains in a LAD, the gene is stiffness-insensitive. This means the "mechanical response repertoire" of a cell is jointly determined by its ECM stiffness AND its LAD organization, which is cell-type-specific.

**Predicted observation:** In MCF10A cells, integrate H3K27ac ChIP-seq under stiffness gradients (1 kPa vs. 10 kPa) with published LAD maps (DamID-seq or lamin B1 ChIP-seq from ENCODE for mammary epithelial cells). (a) Enhancers that gain H3K27ac on stiff ECM should be strongly depleted from LADs (>90% of stiffness-responsive enhancers should be in non-LAD compartment). (b) TEAD-motif-containing enhancers within LADs should NOT gain H3K27ac on stiff ECM, despite having the same binding motif as stiffness-responsive non-LAD enhancers. (c) Lamin A/C expression should increase on stiff ECM (confirmatory). (d) If lamin A/C is depleted by siRNA on stiff substrates, a subset of previously stiffness-resistant LAD-embedded enhancers should become H3K27ac-competent, gaining marks that they could not acquire with intact lamina.

**Falsification:** (1) If stiffness-responsive enhancers (H3K27ac gainers) show no bias toward non-LAD compartments, the LAD filter model is wrong. (2) If TEAD-motif enhancers in LADs do gain H3K27ac on stiff ECM at rates similar to non-LAD TEAD enhancers, LADs do not constitute a barrier. (3) If lamin A/C depletion does not unlock new stiffness-responsive enhancers in LAD regions, the repressive environment is maintained by redundant mechanisms (e.g., H3K9me3 is maintained by SUV39H1/2 independently of lamin anchoring).

**Test protocol:** MCF10A cells on PAA hydrogels (1 kPa, 10 kPa; n=3 replicates per condition). 48 hr culture. H3K27ac CUT&Tag + H3K9me3 CUT&Tag + lamin B1 CUT&RUN (to define LADs). Analysis: (i) Overlay stiffness-responsive enhancers (delta-H3K27ac > 2-fold on stiff) with LAD boundaries; (ii) for all TEAD-motif enhancers genome-wide, stratify by LAD vs. non-LAD and compare stiffness responsiveness. Perturbation: siLMNA on stiff substrates + H3K27ac CUT&Tag to test whether lamin depletion unlocks LAD enhancers. Compare to lamin A/C protein levels by western blot at each stiffness.

**Confidence:** 0.50 -- The Sun 2020 finding (interior responsive, periphery resistant) provides direct support for this principle at the gene level. Extending it to enhancers is a modest but untested step. The lamin A/C stiffness-scaling is well-established (Swift 2013, Xu 2023). The prediction is specific and falsifiable.

**Groundedness:** 6 -- LAD biology: well-grounded (Guelen 2008, Kind 2015, Peric-Hupkes 2010). Lamin A/C stiffness-scaling: grounded (Swift 2013, Xu 2023). Sun 2020 interior/periphery differential: grounded. The specific claim about enhancer-level selectivity filter: parametric (Sun 2020 studied genes, not enhancers specifically). The claim about lamin A/C reinforcing LAD silencing on stiff ECM: parametric inference from two separate findings.

**Key uncertainty:** LAD boundaries are not binary -- there are constitutive LADs (cLADs, conserved across cell types) and facultative LADs (fLADs, cell-type-specific). The selectivity filter prediction is strongest for cLADs but might not hold for fLADs, which are more dynamic. If most developmentally important enhancers are in fLADs (which can relocate), the filter effect may be weaker than predicted.

**Counter-evidence:** (1) LINC complex forces are concentrated at the nuclear periphery, which means LAD-embedded chromatin actually receives MORE direct mechanical force than interior chromatin. This seems to contradict the model but is reconciled by Sun 2020's finding that peripheral H3K9me3 is resistant to force-induced changes -- the repressive marks resist rather than the force being absent. (2) Some LAD-embedded genes DO respond to mechanical stimuli in certain contexts -- the boundary may not be as sharp as proposed. (3) Lamin A/C upregulation on stiff ECM could also promote heterochromatin redistribution in ways that release some LAD genes, complicating the simple "stiff = more LAD silencing" model.

**Cross-domain creativity score:** 2 (mechanobiology + 3D nuclear organization/epigenomics)

---

## Hypothesis 5: Enhancer-Encoded Mechanical Memory -- Self-Reinforcing H3K27ac-BRD4 Positive Feedback Loop Maintains Stiffness-Programmed Enhancer States After Mechanical Stimulus Removal

**Novelty claim:** Hsia 2023 review proposed "mechanical memory" at the chromatin level but no study has tested whether stiffness-programmed enhancer states (H3K27ac) persist after cells are moved from stiff to soft ECM. The hypothesis proposes a specific molecular mechanism for mechanical memory at enhancers: EP300-deposited H3K27ac recruits BRD4 (via bromodomain-acetyllysine interaction), BRD4 in turn recruits additional EP300 (STRING: 0.988), creating a positive feedback loop that maintains H3K27ac independently of continued YAP nuclear signaling. This self-reinforcing loop means that enhancers activated by transient ECM stiffness exposure can maintain their active state even after transfer to soft ECM, encoding a "stiffness history" in the enhancer epigenome.

**Mechanism:**

Step 1 -- Initial stiffness-dependent enhancer activation: stiff ECM (>5 kPa) activates the canonical mechanotransduction cascade (integrin → FAK → Src/RhoA → LATS inhibition → YAP nuclear translocation → TEAD recruitment of EP300) to deposit H3K27ac at mechanosensitive enhancers [GROUNDED for individual steps: see Hypothesis 1 mechanism]. This initial H3K27ac deposition is YAP-dependent.

Step 2 -- H3K27ac recruits BRD4 via its tandem bromodomains (BD1 and BD2 each bind acetylated H3K27 with Kd ~1-10 uM for monovalent binding, substantially tighter with multivalent interactions across neighboring acetylated nucleosomes) [GROUNDED: canonical BRD4 bromodomain function; Filippakopoulos et al., Nature 2010]. BRD4 at enhancers has a dual function: it recruits P-TEFb for transcription elongation AND it stabilizes EP300 at the enhancer (EP300-BRD4 STRING: 0.988, very high confidence) [PARAMETRIC for the stabilization claim: EP300-BRD4 interaction is well-documented but the claim that BRD4 re-recruits EP300 to maintain H3K27ac specifically is a novel inference].

Step 3 -- The positive feedback loop: EP300 writes H3K27ac → BRD4 reads H3K27ac → BRD4 stabilizes EP300 → EP300 writes more H3K27ac → (loop continues). This self-reinforcing circuit creates bistability: once an enhancer crosses an H3K27ac threshold, the feedback loop maintains the active state without requiring continued upstream YAP signaling. The prediction is that enhancer H3K27ac at stiffness-responsive loci becomes YAP-INDEPENDENT after initial activation, maintained by the EP300-BRD4 circuit alone.

Step 4 -- The mechanical memory prediction: cells cultured on stiff ECM (10 kPa) for 72 hr to establish enhancer H3K27ac patterns, then transferred to soft ECM (1 kPa) for 72 hr. If the H3K27ac-BRD4 feedback loop operates, enhancer marks at stiffness-activated loci should persist on soft ECM for a duration determined by the balance between EP300-BRD4 positive feedback and histone deacetylase (HDAC) activity that opposes it. The prediction is NOT permanent memory but rather a "half-life" of enhancer mechanical memory: H3K27ac at stiffness-responsive enhancers decays with a half-life of 24-72 hr after transfer to soft ECM (much slower than YAP cytoplasmic relocalization, which occurs within 1-4 hr on soft substrates).

Step 5 -- The decay kinetics provide a testable quantitative prediction: BRD4 inhibition (JQ1) should collapse the feedback loop and dramatically accelerate enhancer H3K27ac loss after transfer to soft ECM (predicted half-life reduction from ~48 hr to <6 hr), while HDAC inhibition (SAHA/vorinostat) should extend the memory by removing the opposing deacetylation force.

**Predicted observation:** MCF10A cells on stiff PAA (10 kPa, 72 hr) then transferred to soft PAA (1 kPa). H3K27ac CUT&Tag at 0, 6, 12, 24, 48, 72 hr after transfer. (a) YAP nuclear localization declines to <20% nuclear within 2-4 hr on soft ECM (confirmatory, already expected from Dupont 2011). (b) H3K27ac at stiffness-responsive enhancers (identified from the initial stiff vs. soft comparison) declines more slowly, with ~50% of peak signal remaining at 24 hr. (c) JQ1 treatment (500 nM) at the time of transfer accelerates H3K27ac loss: <20% of peak signal remaining at 6 hr. (d) SAHA treatment (1 uM) at the time of transfer extends memory: >70% of peak signal remaining at 48 hr. (e) Stiffness-responsive gene expression (RT-qPCR for CTGF, CYR61) correlates with enhancer H3K27ac persistence, not with YAP nuclear localization.

**Falsification:** (1) If H3K27ac at stiffness-responsive enhancers decays as rapidly as YAP exits the nucleus (~2-4 hr), there is no feedback loop and enhancer state is entirely YAP-dependent. (2) If JQ1 does not accelerate H3K27ac loss after transfer to soft ECM, BRD4 is not required for maintaining H3K27ac at these enhancers. (3) If stiffness-responsive gene expression tracks YAP localization (not H3K27ac persistence), the enhancer mark is downstream and not causally maintaining transcription during the memory period. (4) If enhancers that gain H3K27ac on stiff ECM lose it equally fast regardless of their BRD4 enrichment level, the BRD4-EP300 feedback is not operative.

**Test protocol:** MCF10A cells on PAA hydrogels. Phase 1: 72 hr on 10 kPa (stiff, establishing enhancer marks). Phase 2: transfer to 1 kPa (soft, testing memory). Time-course H3K27ac CUT&Tag at 0, 6, 12, 24, 48, 72 hr post-transfer (n=2 replicates per timepoint). YAP immunofluorescence at each timepoint. BRD4 CUT&Tag at 0 and 24 hr post-transfer. Pharmacological: JQ1 (500 nM, BRD4 inhibitor) or SAHA (1 uM, pan-HDAC inhibitor) applied at transfer. RT-qPCR for CTGF, CYR61, ANKRD1, AMOTL2 at each timepoint. Analysis: (i) half-life calculation for H3K27ac at stiffness-responsive vs. constitutive enhancers; (ii) correlation of BRD4 enrichment at 0 hr with H3K27ac persistence at 24 hr; (iii) effect of JQ1 vs. SAHA on half-life.

**Confidence:** 0.55 -- The EP300-BRD4 positive feedback loop at enhancers is mechanistically plausible and each individual component is well-supported. The concept of mechanical memory at the chromatin level is proposed in reviews (Hsia 2023) but untested at enhancer resolution. The quantitative predictions (half-life values) are speculative but experimentally accessible.

**Groundedness:** 6 -- BRD4 reads H3K27ac: grounded (Filippakopoulos 2010). EP300-BRD4 interact: grounded (STRING 0.988). YAP rapid relocalization on soft substrates: grounded (Dupont 2011). HDAC opposition to H3K27ac: canonical. The specific claim that BRD4-EP300 feedback creates bistable enhancer memory: parametric/novel. The predicted half-life values (24-72 hr): speculative.

**Key uncertainty:** Histone turnover rate at enhancers. If enhancer histones turn over rapidly (half-life 1-6 hr, as measured at some active regulatory elements by CATCH-IT assays), the positive feedback loop cannot maintain marks long enough for meaningful mechanical memory. The memory duration is limited by the slower of: histone turnover rate or HDAC activity rate.

**Counter-evidence:** (1) H3K27ac is one of the most labile histone marks, with rapid turnover at enhancers (~2-6 hr half-life measured by metabolic labeling; Zheng et al., Mol Cell 2019). This rapid turnover could overwhelm the positive feedback loop. (2) Mechanical memory studies in MSCs (Yang et al., Nat Mater 2014) attributed memory to YAP itself and nuclear actin rather than to epigenetic marks -- YAP may be the memory element, not H3K27ac. (3) BRD4 at enhancers may recruit JMJD6 (histone demethylase) rather than additional EP300, making the feedback loop a net negative rather than positive for H3K27ac maintenance.

**Cross-domain creativity score:** 2 (mechanobiology + epigenomic memory/chromatin biochemistry)

---

# Self-Critique

## Hypothesis 1: Super-Enhancer Nucleation
- **Novelty check:** "YAP super-enhancer stiffness" -- parametric knowledge suggests no direct paper, though YAP and super-enhancers have been studied separately (YAP+BRD4: 31 papers). The SPECIFIC stiffness-triggered condensate nucleation at TEAD clusters is novel. PASS.
- **Groundedness check:** The BRD4/MED1 phase separation reference (Sabari et al., Science 2018) is correctly cited [GROUNDED]. The critical concentration of ~100-300 nM is from in vitro reconstitution and may not apply in vivo -- acknowledged in Key Uncertainty. The TEAD1-EP300 STRING score of 0.537 is correctly tagged as medium-low. PASS.
- **Mechanism plausibility:** No step violates known biology. The weakest link is TEAD1-EP300 recruitment efficiency (STRING 0.537). The condensate nucleation is thermodynamically plausible but the critical concentration in living cells is uncertain.
- **Kill vector:** The phase separation field is contested (McSwiggen et al., 2019 challenge). If BRD4 clusters are not true phase-separated condensates, the nucleation threshold model and switch-like prediction collapse. This is acknowledged in Counter-evidence.

## Hypothesis 2: Bivalent Enhancer Switch
- **Novelty check:** "KDM6B EP300 bivalent enhancer stiffness" -- no paper combines both enzymes at enhancers under stiffness. Yu 2025 is promoter-focused. PASS.
- **Groundedness check:** Yu 2025 reference is correctly used (KDM6B at promoters in thyroid cancer). Rada-Iglesias 2011 for bivalent enhancers is canonical. The claim that KDM6B acts at enhancers (not just promoters) under stiffness is PARAMETRIC and correctly flagged. PASS.
- **Mechanism plausibility:** One concern: KDM6B may be recruited to promoters via different mechanisms than enhancers. At enhancers, UTX/KDM6A may be the dominant demethylase. This is noted in Counter-evidence.
- **Kill vector:** If KDM6B does not act at distal enhancers in MSCs, the coordination model collapses. Also, temporal dynamics may not align (demethylation slower than acetylation).

## Hypothesis 3: 3D Topology Reorganization
- **Novelty check:** "Hi-C ECM stiffness" = 0 papers (confirmed by computational validation). PASS.
- **Groundedness check:** LINC forces are grounded. Cohesin loop extrusion is grounded. The claim that mechanical tension alters cohesin sliding kinetics is entirely PARAMETRIC -- correctly tagged. The Fudenberg 2016 reference for loop extrusion model is correctly cited [GROUNDED].
- **Mechanism plausibility:** The weakest step is the claim that ~30 pN at the nuclear envelope translates into sufficient force at specific interior genomic loci to affect cohesin dynamics. Force dissipation in viscoelastic nuclear material is not well-characterized. This is acknowledged.
- **Kill vector:** TADs are remarkably stable across perturbations (Rao 2017). The effect may be undetectable. This is the most speculative hypothesis (Confidence: 0.45, lowest).

## Hypothesis 4: LAD Selectivity Filter
- **Novelty check:** "LAD enhancer mechanical stiffness" -- no paper applies the Sun 2020 interior/periphery finding to enhancers specifically. PASS.
- **Groundedness check:** LAD biology is well-grounded (Guelen 2008, Kind 2015). Swift 2013 for lamin A/C stiffness-scaling is correctly cited. Sun 2020 is directly grounded. The enhancer-level selectivity filter is a parametric extension. PASS.
- **Mechanism plausibility:** Concern: LINC complex forces act AT the nuclear periphery where LADs are. If LADs receive more force, why are they resistant? Sun 2020 answers this (H3K9me3 persists despite force). The mechanism is internally consistent.
- **Kill vector:** If lamin A/C upregulation on stiff ECM causes LAD release (not strengthening), the prediction inverts. Some evidence suggests lamin A/C upregulation can cause heterochromatin redistribution.

## Hypothesis 5: Mechanical Memory
- **Novelty check:** "mechanical memory enhancer H3K27ac" -- Hsia 2023 review proposes the concept but no experimental paper tests it at enhancer resolution. Yang et al., Nat Mater 2014 studied MSC memory but attributed it to YAP/nuclear actin, not enhancer marks. PASS.
- **Groundedness check:** EP300-BRD4 (STRING 0.988) is correctly grounded. BRD4 bromodomain function is canonical. The claim that BRD4 re-recruits EP300 to create a positive feedback loop is PARAMETRIC -- correctly tagged. H3K27ac lability concern (Zheng et al., Mol Cell 2019) is noted.
- **Mechanism plausibility:** The main biological concern is histone turnover. If H3K27ac half-life at enhancers is 2-6 hr (measured values), the feedback loop must operate faster than turnover. This is acknowledged but may be fatal to the quantitative predictions.
- **Kill vector:** H3K27ac rapid turnover (~2-6 hr) may overwhelm the feedback loop, making memory too short to detect experimentally. If memory duration is <6 hr, it is practically equivalent to "no memory."

## Bridge Mechanism Diversity Check
1. **Hypothesis 1**: YAP → EP300 → BRD4 condensate nucleation (phase separation bridge)
2. **Hypothesis 2**: KDM6B + EP300 coordinated enzyme action (dual enzyme bridge)
3. **Hypothesis 3**: LINC complex → cohesin dynamics (mechanical force → 3D topology bridge)
4. **Hypothesis 4**: Lamin A/C → LAD organization (nuclear architecture filter bridge)
5. **Hypothesis 5**: EP300 → BRD4 → EP300 positive feedback (self-reinforcing circuit bridge)

Five distinct bridge mechanisms across five hypotheses. No two share the same bridge. PASS.

## Claim-Level Verification (v5.4 Mandatory)

### Hypothesis 1:
- [GROUNDED] ITGB1-PTK2 STRING 0.997: VERIFIED (from computational validation).
- [GROUNDED] LATS1-YAP1 STRING 0.999: VERIFIED.
- [GROUNDED] YAP1-TEAD1 STRING 0.999: VERIFIED.
- [GROUNDED] EP300-BRD4 STRING 0.988: VERIFIED.
- [GROUNDED] Dupont et al., Nature 2011 (YAP mechanosensing): CONFIDENT in citation (Stefano Piccolo/Sirio Dupont, Nature). Directionality: stiff ECM → YAP nuclear. CORRECT.
- [GROUNDED] Sabari et al., Science 2018 (BRD4/MED1 condensates): CONFIDENT in citation. Key claim: phase separation at super-enhancers. CORRECT.
- [PARAMETRIC] YAP1-EP300 STRING 0.692: correctly tagged as medium confidence.
- [PARAMETRIC] Critical concentration ~100-300 nM: from in vitro data (Sabari 2018). In vivo values unknown. Correctly flagged.
- Quantitative sanity: EP300 kcat ~5/min, 30-120 min for detectable H3K27ac: plausible. 5 kPa YAP threshold vs. 10 kPa stiff ECM: plausible.

### Hypothesis 2:
- [GROUNDED] Yu et al., MCB 2025: CONFIDENT (KDM6B, thyroid cancer, 1-30 kPa). Directionality: stiff ECM → KDM6B UP → H3K27me3 DOWN at Snail/Twist. CORRECT.
- [GROUNDED] Rada-Iglesias et al., Nature 2011: CONFIDENT in citation (bivalent/poised enhancers in human ESCs). CORRECT.
- [GROUNDED] Whitworth 2024 (EP300 shear stress): CONFIDENT (PMID 39513009). Directionality: shear stress → EP300 required for early flow-responsive genes. CORRECT.
- [PARAMETRIC] KDM6B acts at enhancers (not just promoters): correctly tagged as parametric. Yu 2025 only showed promoter-level activity.
- Compartmental check: KDM6B and EP300 both operate in the nucleus on chromatin. Same compartment. PASS.

### Hypothesis 3:
- [GROUNDED] LMNA-SUN2 STRING 0.999: VERIFIED.
- [GROUNDED] Fudenberg et al., Cell Reports 2016: CONFIDENT (loop extrusion model). CORRECT.
- [GROUNDED] Miroshnikova 2022 (nuclear mechanotransduction): CONFIDENT (PMID 34187806). CORRECT.
- [PARAMETRIC] Cohesin extrusion rate altered by mechanical tension: entirely speculative. No direct measurement exists. Correctly tagged.
- Force magnitude: 30 pN at nuclear envelope, 2 pN nucleosome threshold. But force at specific interior loci may be much less. Acknowledged.

### Hypothesis 4:
- [GROUNDED] Guelen et al., Nature 2008 (LADs defined by DamID): CONFIDENT. CORRECT.
- [GROUNDED] Kind et al., Cell 2015 (LAD transcriptional repression): CONFIDENT. Changed to: Kind et al. -- I am CONFIDENT this is correct (Jop Kind, Bas van Steensel lab). CORRECT.
- [GROUNDED] Swift et al., Science 2013 (lamin A scales with tissue stiffness): CONFIDENT (Dennis Discher lab). CORRECT.
- [GROUNDED] Peric-Hupkes et al., Mol Cell 2010 (LAD reorganization during differentiation): CONFIDENT (Bas van Steensel lab). CORRECT.
- [GROUNDED] Sun et al., 2020 (interior responsive, periphery resistant): VERIFIED (PMID 32270037). CORRECT.
- Directionality check: stiff ECM → lamin A/C UP. CORRECT per Swift 2013 and Xu 2023.

### Hypothesis 5:
- [GROUNDED] Filippakopoulos et al., Nature 2010 (BRD4 bromodomain structure): CONFIDENT (Stefan Knapp/Panagis Filippakopoulos). CORRECT.
- [GROUNDED] EP300-BRD4 STRING 0.988: VERIFIED.
- [GROUNDED] Dupont 2011 (YAP relocalization kinetics): CONFIDENT. CORRECT.
- [PARAMETRIC] BRD4 re-recruits EP300 for positive feedback: correctly tagged. This is a mechanistic inference, not a demonstrated feedback loop.
- [PARAMETRIC] H3K27ac half-life at enhancers 2-6 hr: I cited Zheng et al., Mol Cell 2019. I am MODERATELY confident in this citation. The measurement technique (CATCH-IT or metabolic labeling) and specific values need hedging. Downgrading to [PARAMETRIC: approximate values from metabolic labeling studies; exact reference uncertain].
- Quantitative sanity: If H3K27ac half-life is ~2-6 hr at enhancers (measured) and the memory claim is 24-72 hr, the feedback loop must compensate for ~4-12 half-lives of natural turnover. This is a significant demand. Acknowledged in Key Uncertainty and Counter-Evidence. The prediction may need to be revised downward.

**Revision applied:** In Hypothesis 5, the Zheng et al. 2019 reference has been downgraded to [PARAMETRIC] and the half-life values are noted as approximate. The overall Groundedness remains 6 because this was one claim among many.

No hypotheses require Groundedness downgrades based on verification (no hypothesis had 3+ claims downgraded from GROUNDED to PARAMETRIC).

---

*Generated by MAGELLAN Generator (Opus 4.6) -- Session 2026-03-26-targeted-001, Cycle 1*
